CITIGROUP INC - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,666,721
-1.2%
276,918
-7.6%
0.00%0.0%
Q2 2023$2,698,272
+24.0%
299,808
+8.3%
0.00%0.0%
Q1 2023$2,176,481
+16.2%
276,906
-0.1%
0.00%
+100.0%
Q4 2022$1,872,999
+18630.0%
277,071
+41315.7%
0.00%
Q3 2022$10,000
-52.4%
669
-68.8%
0.00%
Q2 2022$21,000
-83.1%
2,147
-74.6%
0.00%
Q1 2022$124,000
-82.7%
8,437
-84.4%
0.00%
Q4 2021$716,000
+41.5%
54,127
+86.7%
0.00%
Q3 2021$506,000
-78.4%
28,988
-70.4%
0.00%
-100.0%
Q2 2021$2,344,000
+269.7%
97,817
+296.3%
0.00%
Q1 2021$634,000
+832.4%
24,685
+590.3%
0.00%
Q4 2020$68,000
+466.7%
3,576
+289.5%
0.00%
Q3 2020$12,000
-57.1%
918
-59.7%
0.00%
Q2 2020$28,000
-6.7%
2,280
-41.3%
0.00%
Q1 2020$30,000
-33.3%
3,887
+53.6%
0.00%
Q4 2019$45,000
+650.0%
2,530
+337.0%
0.00%
Q3 2019$6,000
-91.7%
579
-82.2%
0.00%
Q2 2019$72,000
-79.4%
3,260
-73.4%
0.00%
Q1 2019$350,00012,2380.00%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,719,576$25,679,00012.37%
Vivo Capital, LLC 1,618,296$30,731,0001.37%
Opaleye Management Inc. 470,203$8,929,0001.17%
INTERWEST VENTURE MANAGEMENT CO 388,766$7,383,0000.92%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 177,433$3,369,0000.92%
Ikarian Capital, LLC 1,063,961$20,204,0000.89%
Ghost Tree Capital, LLC 200,000$3,798,0000.85%
Logos Global Management LP 490,000$9,305,0000.80%
Eventide Asset Management 1,680,000$31,903,0000.49%
Affinity Asset Advisors, LLC 45,000$855,0000.45%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders